Twist Bioscience Corporation (TWST)
USD 44.61
(-7.83%)
USD 44.61
(-7.83%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 | -208.72 Million USD | -2.01% |
| 2023 | -204.61 Million USD | 6.08% |
| 2022 | -217.86 Million USD | -43.24% |
| 2021 | -152.09 Million USD | -8.69% |
| 2020 | -139.93 Million USD | -29.96% |
| 2019 | -107.66 Million USD | -51.14% |
| 2018 | -71.23 Million USD | -20.11% |
| 2017 | -59.31 Million USD | -34.53% |
| 2016 | -44.08 Million USD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q1 | -43 Million USD | 7.0% |
| 2024 Q2 | -45.49 Million USD | -5.78% |
| 2024 Q3 | -85.57 Million USD | -88.1% |
| 2023 FY | -204.61 Million USD | 6.08% |
| 2023 Q4 | -46.24 Million USD | 19.43% |
| 2023 Q2 | -59.15 Million USD | -41.44% |
| 2023 Q1 | -41.82 Million USD | 18.18% |
| 2023 Q3 | -57.39 Million USD | 2.98% |
| 2022 Q3 | -60.51 Million USD | 0.25% |
| 2022 Q4 | -51.11 Million USD | 15.54% |
| 2022 FY | -217.86 Million USD | -43.24% |
| 2022 Q1 | -45.56 Million USD | -10.48% |
| 2022 Q2 | -60.66 Million USD | -33.15% |
| 2021 FY | -152.09 Million USD | -8.69% |
| 2021 Q4 | -41.24 Million USD | -3.0% |
| 2021 Q1 | -32.9 Million USD | -35.29% |
| 2021 Q2 | -37.91 Million USD | -15.26% |
| 2021 Q3 | -40.03 Million USD | -5.59% |
| 2020 Q2 | -31.76 Million USD | 42.9% |
| 2020 FY | -139.93 Million USD | -29.96% |
| 2020 Q1 | -55.63 Million USD | -78.44% |
| 2020 Q4 | -24.31 Million USD | 13.79% |
| 2020 Q3 | -28.2 Million USD | 11.21% |
| 2019 Q4 | -31.18 Million USD | -11.7% |
| 2019 FY | -107.66 Million USD | -51.14% |
| 2019 Q3 | -27.91 Million USD | -7.65% |
| 2019 Q2 | -25.93 Million USD | -14.55% |
| 2019 Q1 | -22.63 Million USD | -14.33% |
| 2018 Q1 | -16.93 Million USD | 0.42% |
| 2018 Q2 | -16.87 Million USD | 0.38% |
| 2018 FY | -71.23 Million USD | -20.11% |
| 2018 Q3 | -17.62 Million USD | -4.45% |
| 2018 Q4 | -19.8 Million USD | -12.36% |
| 2017 FY | -59.31 Million USD | -34.53% |
| 2017 Q3 | -14.31 Million USD | 0.0% |
| 2017 Q4 | -17 Million USD | -18.8% |
| 2016 FY | -44.08 Million USD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Bionano Genomics, Inc. | -232.49 Million USD | 10.223% |
| Prenetics Global Limited | -62.72 Million USD | -232.77% |
| Star Equity Holdings, Inc. | -1.54 Million USD | -13383.592% |
| CareDx, Inc | -190.28 Million USD | -9.692% |
| Exact Sciences Corporation | -204.14 Million USD | -2.242% |
| Exagen Inc. | -23.68 Million USD | -781.109% |
| Inotiv, Inc. | -105.14 Million USD | -98.522% |
| Guardant Health, Inc. | -479.44 Million USD | 56.465% |
| Biodesix, Inc. | -52.14 Million USD | -300.272% |
| BioNexus Gene Lab Corp. | -2.62 Million USD | -7839.239% |
| Precipio, Inc. | -5.85 Million USD | -3466.137% |
| iSpecimen Inc. | -11.09 Million USD | -1780.501% |
| Natera, Inc. | -434.8 Million USD | 51.995% |
| Aspira Women's Health Inc. | -16.69 Million USD | -1150.605% |
| Standard BioTools Inc. | -74.65 Million USD | -179.584% |
| 23andMe Holding Co. | -666.7 Million USD | 68.693% |
| Castle Biosciences, Inc. | -57.46 Million USD | -263.217% |
| Personalis, Inc. | -108.29 Million USD | -92.737% |
| Aclaris Therapeutics, Inc. | -88.48 Million USD | -135.899% |
| Applied DNA Sciences, Inc. | -9.94 Million USD | -1998.369% |
| OpGen, Inc. | -32.66 Million USD | -538.921% |
| T2 Biosystems, Inc. | -50.07 Million USD | -316.81% |
| Myriad Genetics, Inc. | -112 Million USD | -86.363% |
| ICON Public Limited Company | 612.33 Million USD | 134.087% |
| NeoGenomics, Inc. | -87.96 Million USD | -137.275% |
| Star Equity Holdings, Inc. | -1.54 Million USD | -13383.592% |
| IDEXX Laboratories, Inc. | 845.04 Million USD | 124.7% |
| RadNet, Inc. | 3.04 Million USD | 6956.965% |
| MDxHealth SA | -43.1 Million USD | -384.283% |
| Psychemedics Corporation | -4.15 Million USD | -4924.699% |
| Illumina, Inc. | -1.16 Billion USD | 82.022% |
| Check-Cap Ltd. | -17.56 Million USD | -1088.103% |
| DarioHealth Corp. | -59.42 Million USD | -251.231% |
| Fulgent Genetics, Inc. | -167.82 Million USD | -24.371% |
| Sera Prognostics, Inc. | -36.24 Million USD | -475.923% |
| ENDRA Life Sciences Inc. | -10.06 Million USD | -1974.76% |
| OPKO Health, Inc. | -188.86 Million USD | -10.517% |
| Medpace Holdings, Inc. | 282.81 Million USD | 173.804% |
| Neogen Corporation | -9.42 Million USD | -2115.54% |
| Intelligent Bio Solutions Inc. | -10.15 Million USD | -1955.045% |
| Prenetics Global Limited | -62.72 Million USD | -232.77% |
| Mainz Biomed B.V. | -26.29 Million USD | -693.764% |
| bioAffinity Technologies, Inc. | -7.93 Million USD | -2529.781% |
| Trinity Biotech plc | -24.01 Million USD | -769.04% |
| Neuronetics, Inc. | -30.18 Million USD | -591.398% |
| Sotera Health Company | 51.37 Million USD | 506.271% |
| bioAffinity Technologies, Inc. | -7.93 Million USD | -2529.781% |